CareDx, Inc.
CDNA
$17.38
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.79% | 14.46% | 14.72% | 25.92% | 19.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.79% | 14.46% | 14.72% | 25.92% | 19.07% |
| Cost of Revenue | 12.35% | 8.22% | 8.41% | 10.01% | 7.55% |
| Gross Profit | 14.49% | 17.71% | 18.13% | 35.29% | 25.66% |
| SG&A Expenses | 0.40% | 2.16% | 1.19% | 1.80% | 3.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.42% | 2.02% | 1.30% | 2.62% | 1.26% |
| Operating Income | 58.92% | 54.80% | 46.63% | 59.97% | 46.67% |
| Income Before Tax | -139.89% | 146.13% | 135.20% | 133.53% | 127.80% |
| Income Tax Expenses | -12.58% | -68.09% | 1,200.00% | 783.33% | 119.86% |
| Earnings from Continuing Operations | -140.64% | 145.97% | 135.00% | 133.30% | 127.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -140.64% | 145.97% | 135.00% | 133.30% | 127.62% |
| EBIT | 58.92% | 54.80% | 46.63% | 59.97% | 46.67% |
| EBITDA | 81.14% | 69.53% | 55.85% | 69.17% | 53.94% |
| EPS Basic | -141.82% | 145.12% | 134.29% | 132.59% | 126.50% |
| Normalized Basic EPS | 70.77% | 66.61% | 56.71% | 69.20% | 53.14% |
| EPS Diluted | -148.35% | 141.00% | 130.54% | 129.28% | 123.32% |
| Normalized Diluted EPS | 70.37% | 67.61% | 57.51% | 69.84% | 53.77% |
| Average Basic Shares Outstanding | 1.01% | 2.94% | 2.51% | 0.72% | -1.85% |
| Average Diluted Shares Outstanding | -0.84% | 4.81% | 4.37% | 2.57% | -0.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |